Alcon articles & resources on Made-in-China.com

Rezvani Introduces 700HP Beast X

Nov 27, 2015

California based automaker Rezvani has introduced the latest model of its Beast lineup, Beast X, which is capable of producing 700hp. The massive power is produced by a 2.4-liter four-cylinder engine featuring dual Borg Warner ...

Tags: Beast X, 2.4-liter four-cylinder engine, turbochargers

Nestle to Invest in Egypt in The Near Furture

Jan 20, 2015

Nestle, Swiss food giant, is going to invest about 1 billion Egyptian pounds ($137.93 million) in Egypt in the next few years. Its North East Africa Region CEO said the kind of investments they have made over the last three to four years ...

Tags: Nestle, food giant

Atom 3S Is Built Upon The Ariel Atom 3 Platform for The US Market

Oct 17, 2014

Ariel Motor Company in collaboration with its manufacturing partner TMI AutoTech has introduced Atom 3S which is built upon the Ariel Atom 3 platform for the US market. The vehicle features Honda 2.4L engine with turbo charging system ...

Tags: Ariel Motor, ATOM 3S

Beverage Can Makers Rexam Has Partnered with The Alcon Group

Sep 10, 2014

Beverage can makers Rexam has partnered with the Alcon group to develop a range of can designs, featuring Spider-Man. This collaboration is a continuation of the development of a licensed product by Marvel and MIO milkshake producer. ...

Tags: Rexam, Spider-Man Cans, Packaging

Rexam Developed a New Can Design for Mio Milkshake

Nov 29, 2013

British packaging company Rexam has developed a new can design for Mio milkshake in collaboration with Alcon Group. The companies have created a 33cl sleek can with bright and concise design for the lemonade flavored milk-based drink, ...

Tags: Aluminum Can, Milkshake

Alcon Has Launched Jetrea to Treat Symptomatic Vitreomacular Adhesion

Nov 25, 2013

Belgium-based biopharmaceutical firm ThromboGenics has announced that its partner Alcon has launched Jetrea (ocriplasmin) for the treatment of symptomatic vitreomacular adhesion (VMA) in Canada. According to the company, Canada is the ...

Tags: Alcon, Vitreomacular Adhesion

ThromboGenics Has Obtained Approval for Jetrea for The Treatment of Symptomatic VMA

Aug 20, 2013

Integrated biopharmaceutical company ThromboGenics has obtained Health Canada approval for Jetrea (ocriplasmin) for the treatment of symptomatic vitreomacular adhesion (VMA). Launch of the drug in Canada will be conducted by Alcon, ...

Tags: Integrated biopharmaceutical, Medicine

ThromboGenics' Jetrea Has Received Approval in The Treatment of Some Adults with VMT

Jun 14, 2013

Biopharmaceutical company ThromboGenics' Jetrea has received approval from UK's National Institute for Health and Care Excellence (NICE) in the treatment of some adults with vitreomacular traction (VMT), a rare eye condition. Known as ...

Tags: Eye Condition Treatment, Medicine

ThromboGenics Announced The Launch of Jetrea in Denmark

May 28, 2013

Integrated biopharmaceutical company ThromboGenics has announced the launch of Jetrea in Denmark and Sweden by Alcon, a division of Novartis. Alcon expects to roll out the European Commission approved Jetrea, which is indicated for the ...

Tags: Medicine, Alcon

The European Commission Has Approved ThromboGenics' Jetrea for The Treatment of VMT

Mar 19, 2013

The European Commission has approved ThromboGenics' Jetrea (ocriplasmin) for the treatment of vitreomacular traction (VMT), including when coupled with macular hole of diameter less than or equal to 400 microns, in the European Union (EU). ...

Tags: ThromboGenics Jetrea, vitreomacular traction treatment, drug

Drug Delivery CRO Particle Sciences Has Developed a New Ocular Formulation

Nov 28, 2012

Drug delivery CRO Particle Sciences has developed a new ocular formulation leveraging its proprietary polymer for Eyeon Therapeutics. The polymer used in the development of the new formulation demonstrated significant results compared to ...

Tags: Proprietary Polymer, Particle Sciences, New Ocular Formulation

Alcon Has Agreed to Buy Sensomotoric Instruments' Ophthalmic Division

Nov 27, 2012

Alcon, a provider of eye care products, has agreed to buy SensoMotoric Instruments' ophthalmic division. SensoMotoric's ophthalmic division products include ocular surgical guidance technology which provides real-time eye tracking, ...

Tags: Alcon, eye care products, ophthalmic division, cataract surgery

Use of Ocular Nsaid in Diabetic Cataract Patients Be Approved By smc

Nov 15, 2012

The Scottish Medicines Consortium (SMC) has approved the use of Alcon's Nevanac in patients suffering from diabetes to minimize the possibility of postoperative macular oedema (MO) coupled with cataract surgery. The approval allows the ...

Tags: The Scottish Medicines Consortium, diabetic cataract patients, Medicine

Lensar Cataract Procedures Carried out in US 26 Sep 2012

Sep 26, 2012

LensAR cataract procedures carried out in US 26 Sep 2012 The country's first commercial procedures using the LensAR femtosecond platform have taken place in two locations. The LensAR Laser System LensAR,the Florida-based vendor of ...

Tags: LensAR, LenSx, OptiMedica, Technolas PV, Laser System, Cataract

Alcon

Related Products